Clinical Trial: Efficacy and Dose-Response Study of Enhanced External Counterpulsation on Blood Pressure in Patients with Prehypertension or Stage 1 Primary Hypertension: A Multicenter, Two-Phase, Double-Blind, Randomized Controlled Trial (China)

China, Aug. 26 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy and Dose-Response Study of Enhanced External Counterpulsation on Blood Pressure in Patients with Prehypertension or Stage 1 Primary Hypertension: A Multicenter, Two-Phase, Double-Blind, Randomized Controlled Trial'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130820

Registration Time: 2026/08/25

Type: Interventional study

Primary Sponsor: The Eighth Affiliated Hospital of Sun Yat-sen University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=324882

Published by HT Digital Content Services with permission from Health Daily Digest....